
Helvetica Chimica Acta p. 543 - 548 (1991)
Update date:2022-09-26
Topics:
Pamingle, Herve
Snowden, Roger L.
Schulte-Elk, Karl H.
Naturally occurring (-)-(R,R)-α -necrodol ((-)-1) and its C(4)-epimer (-)-2 are obtained in 84 and 44% yields, respectively, by lithium ethylenediamide (LEDA) treatment of the corresponding β-necrodols (-)-3 and (-)-4 (Scheme I , Table), both readily available from (-)-campholenyl acetate ((-)-i) by an efficient stereoselective synthesis. The thermodynamically preferred (-)-(R)-y -necrodol ((-)-5) becomes the major product ( ≥ 80 % yield) after either prolonged treatment with LEDA or exposure of α- and β-necrodols to BF3Et2O. In an alternative route, (+)-5 is prepared starting from (+)-campholenal ((+)-ii) via Pd-catalysed decarbonylation to (-)-(S)-1,4,5,5-tetramethylcyclopent-1-ene ((-)-6) and subsequent application of an acid-catalysed CH2O-addition/ rearrangement sequence (Scheme 2).
View MoreContact:+86-0311-84455288-844
Address:Mayu Industrial Park, Jinzhou, Hebei, China.
Chengdu Gelipu Biotechnology Co., Ltd.
website:http://www.glp-china.com
Contact:86-28-82610909
Address:chegndu
Kaiping Genuine Biochemical Pharmaceutical Co.,Ltd.
Contact:+86-750-2881198
Address:No.1, Xinke Road, Shatang Town, Kaiping, Guangdong Province, P.R.China
Contact:+86-021-58123769
Address:No.780 of Cailun Road,Zhangjiang Hi-tech Park,Pudong,Shanghai
Hangzhou Hysen Pharma co.,Ltd.
website:http://www.hysenpharma.cn/
Contact:0086-571-88298791
Address:#701,Gudun Road Hangzhou
Doi:10.1021/ic201841m
(2012)Doi:10.1016/S0040-4039(00)71249-4
(1991)Doi:10.1021/ol203166c
(2012)Doi:10.1021/ic202000b
(2012)Doi:10.1246/bcsj.64.1800
(1991)Doi:10.1246/cl.2011.1363
(2011)